Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats

Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats

We investigated the effect of etoricoxib, a selective cyclooxygenase-2 inhibitor, and indomethacin, a non-selective cyclooxygenase inhibitor, on experimental periodontitis, and compared their gastrointestinal side effects. A ligature was placed around the second upper left molars of female Wistar ra...

Full description

Bibliographic Details
Main Authors:	M.C.F. Azoubel, A.M.A. Menezes, D. Bezerra, R.B. Oriá, R.A. Ribeiro, G.A.C. Brito
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2007-01-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Alveolar bone loss Inflammation Periodontitis Cyclooxygenase inhibitors Etoricoxib Indomethacin
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000100015

Similar Items

Development and Evaluation of Repurposed Etoricoxib Loaded Nanoemulsion for Improving Anticancer Activities against Lung Cancer Cells
by: Shadab Md, et al.
Published: (2021-12-01)

Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib
by: Tjandrawinata RR, et al.
Published: (2018-04-01)

ETORICOXIB: THERAPEUTIC POTENTIAL
by: A. E. Karateev
Published: (2009-03-01)

Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions
by: Jessica Meulman, et al.
Published: (2023-11-01)

Etoricoxib‐induced pleural effusion: A case report
by: Bishal Kumar Sah, et al.
Published: (2023-11-01)

Pre-emptive 8 mg dexamethasone and 120 mg etoricoxib for pain prevention after periodontal surgery: A randomised controlled clinical trial
by: Kranti Konuganti, et al.
Published: (2015-01-01)

Etoricoxib (arcoxia) in rheumatology
by: Fatima Magomedovna Kudaeva, et al.
Published: (2011-06-01)

Effects of indomethacin on prostanoid synthesis and vasomotor responsiveness in endothelium-denuded abdominal and thoracic aortas of Wistar rats
by: Ruth M. López, et al.
Published: (2017-04-01)

Complete form of pachydermoperiostosis with good initial response to etoricoxib: A case report
by: Abinash Baniya, et al.
Published: (2023-06-01)

Analgesia na entorse de tornozelo: estudo com etoricoxibe
by: Rogério Teixeira da Silva, et al.

A case of wet purpura due to etoricoxib induced thrombocytopenia
by: Robin George Manappallil
Published: (2016-08-01)

A simple Ultraviolet spectrophotometric method for the determination of etoricoxib in dosage formulations
by: Shipra Singh, et al.
Published: (2012-01-01)

Etoricoxib in the treatment of osteoarthritis
by: S. G. Anikin, et al.
Published: (2020-03-01)

A case of toxic epidermal necrolysis probably due to etoricoxib
by: Sayanta Thakur, et al.
Published: (2019-01-01)

Fast and Sensitive HPLC-ESI-MS/MS Method for Etoricoxib Quantification in Human Plasma and Application to Bioequivalence Study
by: Gabriel Onn Kit Loh, et al.
Published: (2022-09-01)

Synthesis of Some New Amides Derived from Indomethacin
by: Kawther Al-Naimi, et al.
Published: (2013-12-01)

Do etoricoxib and indometacin have similar effects and safety for gouty arthritis? A meta-analysis of randomized controlled trials
by: Lin TM, et al.
Published: (2018-12-01)

Formulation Development, Statistical Optimization, In Vitro and In Vivo Evaluation of Etoricoxib-Loaded Eucalyptus Oil-Based Nanoemulgel for Topical Delivery
by: Nabil A. Alhakamy, et al.
Published: (2021-08-01)

Psychosis secondary to indomethacin. A case report
by: S. Santiago González, et al.
Published: (2021-04-01)

Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles
by: Joanna Kuźmińska, et al.
Published: (2023-08-01)

Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis
by: Yong Sun, et al.
Published: (2020-04-01)

Formulation and evaluation of indomethacin biomicroparticles
by: Sudeep Gupta, et al.
Published: (2012-01-01)

Novel analytical method based on chemometric models applied to UV–Vis spectrophotometric data for simultaneous determination of Etoricoxib and Paracetamol in presence of Paracetamol impurities
by: Mona A. Abdel Rahman, et al.
Published: (2023-12-01)

Stability Study of Etoricoxib a Selective Cyclooxygenase-2 Inhibitor by a New Single and Rapid Reversed Phase HPLC Method
by: Muhammad Alzweiri, et al.
Published: (2018-07-01)

Formulation and Evaluation of Cox-2 Inhibitor (Etoricoxib) Loaded Ethyl Cellulose Nanoparticles for Topical Drug Delivery
by: Abbaraju Krishna Sailaja, et al.
Published: (2018-03-01)

The efficacy and safety of etoricoxib versus meloxicam in the treatment of patients with gonarthrosis
by: B V Zavodovsky, et al.
Published: (2016-12-01)

Ascorbic Acid Ameliorates Cardiac and Hepatic Toxicity Induced by Azithromycin-Etoricoxib Drug Interaction
by: Reham Z. Hamza, et al.
Published: (2022-05-01)

ETORICOXIB IS A NEW SELECTIVE CYCLOOXYGENASE-2 INHIBITOR
by: A E Karateev
Published: (2009-06-01)

Bidirectional interactions between indomethacin and the murine intestinal microbiota
by: Xue Liang, et al.
Published: (2015-12-01)

The Role of Indomethacin in Isolated Polyhydramnios
by: Greeshma Singham1 , Achanta Vivekanand2 , Satyaprabha Siripurapu2 , SubhaRanjan Samantaray2
Published: (2020-08-01)

Formulation and Evaluation of Etoricoxib Niosomes by Thin Film Hydration Technique and Ether Injection Method
by: Veldurthi Ravalika, et al.
Published: (2017-09-01)

Etoricoxib is safe and effective in preventing heterotopic ossification after primary total hip arthroplasty
by: Stella Oberberg, et al.
Published: (2021-02-01)

Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis
by: I Z Gaĭdukova, et al.
Published: (2014-12-01)

Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis
by: I Z Gaydukova, et al.
Published: (2015-03-01)

Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers
by: El-Maghawry E, et al.
Published: (2020-06-01)

Validated HPLC–PDA methodology utilized for simultaneous determination of Etoricoxib and Paracetamol in the presence of Paracetamol toxic impurities
by: Mona A. Abdel Rahman, et al.
Published: (2022-12-01)

Comparative evaluation of the safety and efficacy of etoricoxib and diclofenac on the upper gastrointestinal tract in patients with osteoarthrosis and rheumatoid arthritis (the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program)
by: L I Alekseyeva
Published: (2010-08-01)

Design, Synthesis, In Silico and In Vitro Studies for New Nitric Oxide-Releasing Indomethacin Derivatives with 1,3,4-Oxadiazole-2-thiol Scaffold
by: Alexandru Sava, et al.
Published: (2021-06-01)

The blockade of cyclooxygenases-1 and -2 reduces the effects of hypoxia on endothelial cells
by: Gloria M.A., et al.
Published: (2006-01-01)

Evaluation of chemopreventive response of two cycloxygenase-2 inhibitors, etoricoxib and diclofenac in rat colon cancer using FTIR and NMR spectroscopic techniques Evaluación de la respuesta quimiopreventiva de dos inhibidores de la ciclooxigenasa 2, etoricoxib y diclofenaco en el cáncer de colon murino empleando las técnicas espectroscópicas FTIR Y NMR
by: M. Kaur Saini, et al.
Published: (2010-08-01)